Temporary dose reductions during particularly symptomatic periods, followed by re-escalation once symptoms stabilize, represents a common clinical approach
Standard semaglutide dosing protocol in units The FDA-approved titration schedule for semaglutide weight management follows a gradual ramp-up over 16 to 20 weeks
Introducing new medicines in the NHS in the UK pathway
Knowing what to expect and how to respond prevents minor issues from becoming serious problems
Through a personalized titration plan, theyll monitor how your body responds and make thoughtful adjustments to your dose, so you can progress at your own pace without compromising safety
In 2023, the FDA approved tirzepatide for obesity, which, according to Gratzl and colleagues, contributed to an increase in prescribing trends of GLP-1 medications